Helsinki Urological Cancer Center (HUCC) focuses around the clinical and academic work done at the HUS Helsinki University Hospital and Helsinki University.
Department of urology is the largest in Finland.
MD Kevin Sandeman will defend his doctoral dissertation on 10th November 2023 at 1 PM at the Faculty of Medicine, University of Helsinki, on the topic ‘Building Blocks of Prostate Cancer Diagnostics.’ The defense will take place at Biomedicum, room 2, Haartmaninkatu 8. The event will be live streamed.
Minna Malmstedt has been working at the Helsinki Urological Cancer Center as a research coordinator for over 4 years. When Malmstedt started working at HUCC, she hoped for a varied role. Her wishes were taken into account, and her role was built to suit her unique talents. Now most of her time at work is spent coordinating research projects between clinicians, researchers, and patients.
Timo-Pekka Lehto started working on his PhD when he was in the third year of medical school. Now he works full-time at HUCC. Lehto’s PhD project is about molecular biomarkers in prostate cancer; specifically, messenger-RNA biomarkers for improved risk stratification of surgically treated intermediate- to high grade prostate cancer.
Tuomas Mirtti is a pathologist and a research group leader in Helsinki Urological Cancer Center. Currently, he is based in Atlanta, USA, where he works as a visiting associate professor at Emory University. Overall, his goal is to bring robust AI models to digital pathology.
Abderrahim Oussama Batouche is a PhD Student in Helsinki Urological Cancer Center. He has a background in Data science and Bioinformatics. His thesis aims to develop AI methods to identify patients at high risk of PCa and those with low-risk tumours, improving treatment decisions.
As biomedical laboratory scientists, Miia Kokkola and Suvi Karvonen’s job involves processing samples from research participants, generating laboratory requests, providing customer service, and participating in the development of research operations.
Prostate cancer research group, co-led by assistant professor Antti Rannikko (clinical site) and associate professor Tuomas Mirtti (pathology and preclinical site) is the core of the Helsinki Prostate Cancer Research Center (PCRC).
Kidney cancer research group is an active and growing group of researchers led by associate professor Harry Nisen (urology). The group has several retrospective and prospective studies and trials ongoing and on the pipeline. It actively collaborates with local, national and international experts in clinical, translational and preclinical collaborative projects.
Bladder cancer group is co-led by urologist, PhD, Jukka Sairanen (invasive bladder cancer) and urologist, PhD, Riikka Järvinen (superficial bladder cancer).
The group has several retrospective and prospective studies and trials ongoing and on the pipeline. It actively collaborates with local, national and international experts in clinical, translational and preclinical collaborative projects.
Testicular cancer research group is co-led by urologist, PhD, Hanna Vasarainen and associate professor Otto Hemminki.
Helsinki Urological Cancer Research Group centers around the clinical and academic work done at the HUS Helsinki University Hospital and Helsinki University. Department of urology is the largest in Finland with an catchment area of ca. 1.5M inhabitants and 25 staff members. Our center is a tertiary referral center for centralized surgery (e.g. Cystectomy, prostatectomy, urethraplasty, RPLND) but at the same time also responsible for the primary diagnostics, treatments and follow-up of all urological cancers in greater Helsinki area.